This tender invites sealed bids for the supply of medicines, disposables, lab kits, and implants for the Daily LP FY 2026/27 at Combined Military Hospital (CMH) Gilgit. The procurement is managed by CMH Gilgit, located in Gilgit-Baltistan, focusing on pharmaceutical and medical supplies essential for hospital operations and patient care. The scope includes a comprehensive range of medicines and medical consumables required for daily use. Suppliers must ensure quality and compliance with health standards. The delivery location is CMH Gilgit, where timely and efficient supply is critical to maintain uninterrupted medical services. The tender requires firms to be registered with the Securities and Exchange Commission of Pakistan (SECP) and preferably with the Directorate General Defence Purchase (DGDP). Registration with the Ministry of Health and active status on the Federal Board of Revenue (FBR) sales tax list is mandatory. Bidders should have a valid PEC category relevant to pharmaceuticals or medical supplies and must comply with FBR's Active Taxpayer List (ATL) requirements for the fiscal year 2025-26. It is advisable to prepare the Earnest Money in the form of a Call Deposit Receipt (CDR) as per PPRA rules. The tender documents can be obtained from the Medical Officer In-charge at CMH Gilgit during office hours. The submission deadline is set for 10:00 AM on the 26th of March, 2026, with the technical and financial bids to be submitted in separate sealed envelopes clearly marked. The bids will be opened the same day at 11:00 AM in the presence of bidders' representatives at CMH Gilgit. The physical submission method is sealed hard copy delivery to the Medical Officer In-charge, Medical Store, CMH Gilgit. Pro-Tip: Make sure to carefully follow PPRA Rule 36B by submitting separate envelopes for Technical and Financial Proposals to avoid disqualification. Also, verify the Earnest Money requirements and ensure your firm's registration and tax status are up to date to prevent rejection at the technical evaluation stage.